Pancreatic exocrine insufficiency after pancreaticoduodenectomy: Current evidence and management
World Journal of Gastrointestinal Pathophysiology · 12.04.2020 · 11 (2) · 20-31
DOI: 10.4291/wjgp.v11.i2.20 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift World Journal of Gastrointestinal Pathophysiology, erschienen am 12.04.2020. Verfasst von Adithya M Pathanki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of HPB and Liver Transplantation, Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham B15 2TH, United Kingdom. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Pancreaticoduodenectomy (PD) is the commonest procedure performed for pancreatic cancer. Pancreatic exocrine insufficiency (PEI) may be caused or exacerbated by surgery and remains underdiagnosed and undertreated. The aim of this review was to ascertain the incidence of PEI, its consequences and management in the setting of PD for indications other than chronic pancreatitis. A literature search of databases (MEDLINE, EMBASE, Cochrane and Scopus) was carried out with the MeSH terms "pancreatic exocrine insufficiency" and "Pancreaticoduodenectomy". Studies that analysed PEI and its complications in the setting of PD for malignant and benign disease were included. Studies reporting PEI in the setting of PD for chronic pancreatitis, conference abstracts and reviews were excluded. The incidence of PEI approached 100% following PD in some series. The pre-operative incidence varied depending on the characteristics of the patient cohort and it was higher (46%-93%) in series where pancreatic cancer was the predominant indication for surgery. Variability was also recorded with regards to the method used for the diagnosis and evaluation of pancreatic function and malabsorption. Pancreatic enzyme replacement therapy is the mainstay of the management. PEI is common and remains undertreated after PD. Future studies are required for the identification of a well-tolerated, reliable and reproducible diagnostic test in this setting.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of HPB and Liver Transplantation, Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham B15 2TH, United Kingdom.
- Department of Nutrition and Dietetics, Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham B15 2TH, United Kingdom.
- Department of HPB and Liver Transplantation, Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham B15 2TH, United Kingdom. chatzizacharias@gmail.com.
Zitieren
APA
Pathanki, A. M., Attard, J. A., Bradley, E., Powell-Brett, S., Dasari, B. V. M., Isaac, J. R., Roberts, K. J., & Chatzizacharias, N. A. (2020). Pancreatic exocrine insufficiency after pancreaticoduodenectomy: Current evidence and management. World Journal of Gastrointestinal Pathophysiology, 11(2), 20-31. https://doi.org/10.4291/wjgp.v11.i2.20
Vancouver
Pathanki AM, Attard JA, Bradley E, Powell-Brett S, Dasari BVM, Isaac JR, et al. Pancreatic exocrine insufficiency after pancreaticoduodenectomy: Current evidence and management. World Journal of Gastrointestinal Pathophysiology. 2020;11(2):20-31. doi:10.4291/wjgp.v11.i2.20
BibTeX
@article{Pathanki2020,
author = {Pathanki, Adithya M and Attard, Joseph A and Bradley, Elizabeth and Powell-Brett, Sarah and Dasari, Bobby V M and Isaac, John R and Roberts, Keith J and Chatzizacharias, Nikolaos A},
title = {Pancreatic exocrine insufficiency after pancreaticoduodenectomy: Current evidence and management},
journal = {World Journal of Gastrointestinal Pathophysiology},
year = {2020},
volume = {11},
number = {2},
pages = {20--31},
doi = {10.4291/wjgp.v11.i2.20}
}
EUVIMED